TRIL > Trillium Therapeutics launches equity offering; shares down 9% after hours
May 25, 2017 4:09 PM ET|About: Trillium Therapeutics ... (TRIL)|By: Douglas W. House, SA News Editor
Trillium Therapeutics (NASDAQ:TRIL) commences a public offering of common stock and Series II Non-Voting Convertible Preferred Stock. Prices, volumes and terms have yet to be announced. Net proceeds will fund clinical trials, working capital and general corporate purposes.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.